TipRanks
Go Ultimate55% OFF

CS Diagnostics (CSDX) Financial Statements

CS Diagnostics Financial Overview

CS Diagnostics's market cap is currently $1.82M. The company's EPS TTM is $0.00; its P/E ratio is 36.50; CS Diagnostics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 23
Income Statement
Total Revenue$ 204.00K$ 126.04K
Gross Profit$ 0.00$ 126.04K
Operating Income$ 71.22K$ -22.00K
EBITDA$ 71.22K$ -22.00K
Net Income$ 71.22K$ -22.00K
Balance Sheet
Cash & Short-Term Investments$ 6.81K$ 20.36K
Total Assets$ 499.49M$ 499.42M
Total Debt$ 0.00$ 0.00
Net Debt$ -6.81K$ -20.36K
Total Liabilities$ 15.26K$ 12.82K
Stockholders' Equity$ 499.47M$ 499.41M
Cash Flow
Free Cash Flow$ 6.31K$ -499.44M
Operating Cash Flow$ 6.31K$ 9.29K
Investing Cash Flow$ 0.00$ -499.44M
Financing Cash Flow$ 0.00$ 499.42M

Currency in USD

CS Diagnostics Earnings and Revenue History

-120K0120K240K-25 %0 %25 %50 %EarningsProfit Margin20232025RevenueEarningsProfit Margin

CS Diagnostics Debt to Assets

0200M400M600M0.0025 %0.00275 %0.003 %0.00325 %LiabilitiesDebt to Assets20232025AssetsLiabilitiesDebt to Assets

CS Diagnostics Cash Flow

-750M-500M-250M0250M500M750M20232025OperatingInvestingFinancing

CS Diagnostics Forecast EPS vs Actual EPS